The World’s Largest Clinical Study Is Examining the World’s Oldest Wonderdrug, National Institute for Health Research Reveals
The world’s largest clinical study is about to begin, and it’s only aimed at studying one thing: aspirin.
The study, which includes 11,000 patients across the U.K. and will take 12 years to complete, aims to understand the impact that aspirin can have on different types of cancer. The patients involved in the study, all of whom have been treated for either bowel, breast, oesophageal, prostate, or stomach cancer, will take either 100 mg of aspirin, 300 mg of aspirin, or a placebo throughout the study’s course.
Help employers find you! Check out all the jobs and post your resume.
The study, which includes 11,000 patients across the U.K. and will take 12 years to complete, aims to understand the impact that aspirin can have on different types of cancer. The patients involved in the study, all of whom have been treated for either bowel, breast, oesophageal, prostate, or stomach cancer, will take either 100 mg of aspirin, 300 mg of aspirin, or a placebo throughout the study’s course.
Help employers find you! Check out all the jobs and post your resume.